Innova Captab Limited
NSE: INNOVACAP
NSE
676.75
-14.35 (-2.08%)
Prev Close
691.1
Open Price
738.8
Volume
65,535
Today Low / High
676.6 / 738.8
52 WK Low / High
421.35 / 1260
Range
643 - 711
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 676.75, with a change of -14.35 (-2.0764%). The expected target range on the NSE is between 643 - 711. The stock is experiencing a downward trend on the NSE. Investors should be cautious as the price is currently declining.
04 Mar
738.80
-8.34%
03 Mar
725.00
-4.68%
28 Feb
772.15
-5.99%
27 Feb
776.70
-2.05%
25 Feb
770.00
0.87%
24 Feb
772.65
-0.34%
21 Feb
830.00
-5.52%
20 Feb
815.10
-0.45%
19 Feb
775.00
4.98%
18 Feb
796.30
-3.06%
17 Feb
813.70
-1.76%
14 Feb
843.00
-2.11%
13 Feb
854.65
-1.95%
12 Feb
840.00
0.24%
11 Feb
900.60
-5.46%
10 Feb
926.00
-2.74%
07 Feb
939.00
-1.47%
06 Feb
978.00
-2.81%
05 Feb
1,011.90
-0.46%
04 Feb
1,000.00
0.80%
Innova Captab Limited Graph
Innova Captab Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking Target Price for Innova Captab Limited T1, T2, T3, for both Bullish or Bearish. For Bullish T1, T2, T3 and for Bearish T1, T2, T3. The stock current price is 677, with potential price targets ranging from T1, T2, T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 676.75 | 683.52 | 615.17 - 751.87 |
| 690.29 | 552.23 - 828.34 | ||
| 697.05 | 487.94 - 906.17 | ||
| Bearish Scenario | 676.75 | 669.98 | 602.98 - 736.98 |
| 663.22 | 530.57 - 795.86 | ||
| 656.45 | 459.51 - 853.38 |
Overview of Innova Captab Limited
ISIN
INE0DUT01020
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
92,401
Market Cap
38,812,808,773
Last Dividend
0
Official Website
IPO Date
2023-12-29
DCF Diff
789.86
DCF
-99
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 1,076.96 Cr | 734.86 Cr | 342.10 Cr | 0.3177 | 0.00 Cr | 91.57 Cr | 253.34 Cr | 94.35 Cr | 18.66 | 166.83 Cr | 0.0876 |
| 2023-03-31 | 926.38 Cr | 691.56 Cr | 234.82 Cr | 0.2535 | 0.00 Cr | 0.00 Cr | 111.77 Cr | 67.95 Cr | 11.87 | 122.83 Cr | 0.0734 |
| 2022-03-31 | 799.77 Cr | 626.40 Cr | 173.38 Cr | 0.2168 | 0.00 Cr | 1.65 Cr | 91.15 Cr | 63.95 Cr | 11.18 | 98.77 Cr | 0.0800 |
| 2021-03-31 | 409.56 Cr | 314.31 Cr | 95.26 Cr | 0.2326 | 0.00 Cr | 1.22 Cr | 49.97 Cr | 34.50 Cr | 6.03 | 55.86 Cr | 0.0842 |
| 2020-03-31 | 373.32 Cr | 285.43 Cr | 87.89 Cr | 0.2354 | 0.00 Cr | 0.00 Cr | 67.57 Cr | 27.89 Cr | 5.81 | 50.62 Cr | 0.0747 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 11.73 Cr | 1,320.88 Cr | 489.99 Cr | 830.8940 Cr | 245.10 Cr | 233.38 Cr | 144.02 Cr | 681.08 Cr | 13.10 Cr | 0.00 Cr | -69.80 Cr | 265.4810 Cr |
| 2023-03-31 | 13.29 Cr | 1,018.72 Cr | 693.13 Cr | 325.5820 Cr | 432.77 Cr | 419.48 Cr | 156.33 Cr | 357.88 Cr | 50.85 Cr | 0.09 Cr | -48.03 Cr | 391.4790 Cr |
| 2022-03-31 | 0.15 Cr | 575.48 Cr | 366.87 Cr | 208.6060 Cr | 199.17 Cr | 199.02 Cr | 128.39 Cr | 165.92 Cr | 17.36 Cr | 0.09 Cr | -0.69 Cr | 294.5190 Cr |
| 2021-03-31 | 4.80 Cr | 369.62 Cr | 224.80 Cr | 144.8210 Cr | 45.50 Cr | 40.70 Cr | 91.45 Cr | 85.96 Cr | 56.88 Cr | 0.13 Cr | 0.00 Cr | 215.1530 Cr |
| 2020-03-31 | 0.00 Cr | 0.00 Cr | 0.17 Cr | 0.0000 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.17 Cr | 0.00 Cr | 0.0000 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 146.3400 Cr | -498.9710 Cr | 360.8340 Cr | -141.0130 Cr | 8.2030 Cr | 11.7280 Cr | -287.3530 Cr | 129.5290 Cr | 53.6080 Cr | 0.0000 Cr | 1.5400 Cr |
| 2023-03-31 | 67.1240 Cr | -90.8430 Cr | 27.0920 Cr | -11.8670 Cr | 3.3730 Cr | 3.5250 Cr | -78.9910 Cr | 91.7950 Cr | -9.8320 Cr | 0.0000 Cr | 10.8420 Cr |
| 2022-03-31 | 58.8980 Cr | -188.1150 Cr | 124.5740 Cr | -20.9850 Cr | -4.6430 Cr | 0.1520 Cr | -79.8830 Cr | 85.7200 Cr | 130.8850 Cr | 0.0000 Cr | -11.4310 Cr |
| 2021-03-31 | 41.5660 Cr | -19.6680 Cr | -19.3360 Cr | 22.8330 Cr | 2.5620 Cr | 4.7950 Cr | -18.7330 Cr | 46.3440 Cr | -15.7070 Cr | 0.0000 Cr | -4.4100 Cr |
| 2020-03-31 | 30.7970 Cr | -6.0380 Cr | -23.2760 Cr | 26.5670 Cr | 1.4830 Cr | 2.2330 Cr | -4.2300 Cr | 27.8860 Cr | -14.8620 Cr | 0.0000 Cr | -26.7640 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 316.46 Cr | 209.93 Cr | 106.53 Cr | 0.3366 | 0.00 Cr | 34.20 Cr | 5.97 | 50.89 Cr | 0.1081 |
| 2024-09-30 | 318.20 Cr | 206.98 Cr | 111.22 Cr | 0.3495 | 44.74 Cr | 35.00 Cr | 6.12 | 51.95 Cr | 0.1100 |
| 2024-06-30 | 294.27 Cr | 199.16 Cr | 95.11 Cr | 0.3232 | 37.32 Cr | 29.48 Cr | 5.15 | 44.30 Cr | 0.1002 |
| 2024-03-31 | 262.63 Cr | 168.36 Cr | 94.28 Cr | 0.3590 | 40.36 Cr | 28.72 Cr | 5.68 | 43.76 Cr | 0.1094 |
| 2023-12-31 | 302.49 Cr | 202.08 Cr | 100.40 Cr | 0.3319 | 42.01 Cr | 25.13 Cr | 4.39 | 46.94 Cr | 0.0831 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 3.38 Cr | 21.52 Cr | 24.89 Cr | 0.00 Cr | 175.19 Cr | 585.06 Cr | 795.80 Cr | 1,434.55 Cr | 539.25 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 84.09 Cr | 0.00 Cr | 0.00 Cr | 84.09 Cr | 0.00 Cr | 0.00 Cr | -830.89 Cr |
| 2024-03-31 | 11.73 Cr | 82.65 Cr | 94.38 Cr | 288.49 Cr | 144.02 Cr | 579.75 Cr | 681.08 Cr | 1,320.88 Cr | 489.99 Cr |
| 2023-12-31 | 0.00 Cr | 0.00 Cr | 60.46 Cr | 0.00 Cr | 0.00 Cr | 60.46 Cr | 0.00 Cr | 0.00 Cr | -388.53 Cr |
| 2023-09-30 | 60.46 Cr | 0.00 Cr | 60.46 Cr | 301.41 Cr | 146.40 Cr | 567.27 Cr | 507.67 Cr | 1,173.49 Cr | 784.96 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 29.48 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 28.72 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 25.13 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 3.92 Cr | 3.92 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 22.91 Cr | 30.64 Cr | -126.17 Cr | 67.03 Cr | -28.50 Cr | 3.92 Cr | 32.41 Cr | -121.50 Cr | -90.86 Cr |
| 2023-06-30 | 24.60 Cr | 47.39 Cr | -219.75 Cr | 201.25 Cr | 28.89 Cr | 32.41 Cr | 3.53 Cr | -29.79 Cr | 17.60 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,558.65 | ₹3,739,637,772,000.00 | ₹781,719.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹5,506.25 | ₹1,461,738,681,250.00 | ₹64,908.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹2,949.60 | ₹998,277,372,000.00 | ₹166,276.00 |
| Mankind Pharma Limited | MANKIND | ₹2,291.25 | ₹945,320,533,950.00 | ₹177,711.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,114.75 | ₹928,700,476,795.00 | ₹434,095.00 |
| Lupin Limited | LUPIN | ₹1,934.60 | ₹883,108,142,600.00 | ₹259,741.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹870.20 | ₹875,621,346,000.00 | ₹343,556.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,050.85 | ₹610,335,781,700.00 | ₹413,280.00 |
| Alkem Laboratories Limited | ALKEM | ₹4,591.20 | ₹548,946,828,000.00 | ₹17,608.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,313.55 | ₹370,668,047,400.00 | ₹97,865.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,339.40 | ₹339,811,137,600.00 | ₹56,310.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,451.70 | ₹306,246,750,400.00 | ₹61,223.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,161.90 | ₹295,779,073,500.00 | ₹165,600.00 |
| Laurus Labs Limited | LAURUSLABS | ₹541.60 | ₹292,059,424,800.00 | ₹1,255,902.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,614.85 | ₹251,280,349,100.00 | ₹29,467.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,238.20 | ₹201,165,401,200.00 | ₹280,998.00 |
| Piramal Enterprises Limited | PEL | ₹877.00 | ₹197,744,206,000.00 | ₹172,994.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹7,180.00 | ₹179,500,000,000.00 | ₹18,235.00 |
| Eris Lifesciences Limited | ERIS | ₹1,181.00 | ₹160,768,349,000.00 | ₹22,410.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹775.65 | ₹152,464,090,950.00 | ₹312,147.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹917.85 | ₹146,196,065,850.00 | ₹70,165.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹11,307.10 | ₹145,068,962,290.00 | ₹40,103.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹801.90 | ₹143,628,309,000.00 | ₹553,341.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,794.05 | ₹136,368,790,385.00 | ₹351,707.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹474.45 | ₹115,051,278,300.00 | ₹761,172.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,120.00 | ₹84,988,928,000.00 | ₹2,119.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹733.60 | ₹66,483,240,936.00 | ₹180,483.00 |
| FDC Limited | FDC | ₹380.40 | ₹61,932,924,000.00 | ₹76,550.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹623.30 | ₹60,953,067,970.00 | ₹158,952.00 |
| Strides Pharma Science Limited | STAR | ₹606.80 | ₹55,924,326,360.00 | ₹175,466.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹912.85 | ₹46,298,930,435.00 | ₹61,199.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹630.35 | ₹44,380,296,030.00 | ₹15,929.00 |
| Hikal Limited | HIKAL | ₹353.10 | ₹43,537,583,100.00 | ₹104,019.00 |
| Innova Captab Limited | INNOVACAP | ₹676.60 | ₹38,718,387,638.00 | ₹65,536.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹117.03 | ₹37,978,809,660.00 | ₹840,880.00 |
| Sequent Scientific Limited | SEQUENT | ₹145.38 | ₹36,388,904,760.00 | ₹484,563.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,080.00 | ₹34,401,120,000.00 | ₹13,355.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹316.20 | ₹31,707,903,600.00 | ₹60,257.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹346.80 | ₹31,652,436,000.00 | ₹50,219.00 |
| Suven Life Sciences Limited | SUVEN | ₹116.15 | ₹25,329,295,100.00 | ₹387,876.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹45.64 | ₹25,008,620,560.00 | ₹2,413,022.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹469.75 | ₹23,648,166,244.00 | ₹100,544.00 |
| Alembic Limited | ALEMBICLTD | ₹89.77 | ₹23,051,320,050.00 | ₹318,318.00 |
| Indoco Remedies Limited | INDOCO | ₹226.93 | ₹20,933,815,947.00 | ₹228,598.00 |
| Bajaj HealthCare Limited | BAJAJHCARE | ₹635.05 | ₹20,056,974,665.00 | ₹289,638.00 |
Key Executives
Company Secretary & Compliance Officer
Ms. Neeharika Shukla
Gender: female
Year Born:
Whole-time Director
Mr. Jayant Vasudeo Rao
Gender: male
Year Born: 1964
Deputy Chief Financial Officer
Mr. Mukesh Kumar Singh
Gender: male
Year Born:
Company Secretary
Ms. Priyanka Jangid
Gender: female
Year Born:
Executive Chairman
Mr. Manoj Kumar Lohariwala
Gender: male
Year Born: 1972
MD & Director
Mr. Vinay Kumar Lohariwala
Gender: male
Year Born: 1976
Chief Financial Officer
Mr. Lokesh Bhasin
Gender: male
Year Born:
Company Secretary of Sharon Bio - Medicine Limited
Ms. Rakhi Makhloga
Gender: female
Year Born:
FAQs about Innova Captab Limited
Who is the CEO of the company?
The CEO is Mr. Manoj Kumar Lohariwala.
What is the current market price of the stock?
The current price is ₹678.25.
What is the 52-week price range?
The range is ₹421.35-1260.
What is the market capitalization of the company?
The market capitalization is ₹3,881.28 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 30.50.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Innova Captab Limited (ISIN: INE0DUT01020) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹3,881.28 crores and an average daily volume of 92,401 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.